BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Treatment
6 results:

  • 1. fat1 inhibits AML autophagy and proliferation via downregulating ATG4B expression.
    Zhang N; Shen MY; Meng QL; Sun HP; Fan FY; Yi H; Yang YJ
    Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130519. PubMed ID: 37952564
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic leukemia.
    Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
    Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
    Tatarczuch M; Waltham M; Shortt J; Polekhina G; Hawkes EA; Ho SJ; Trotman J; Brasacchio D; Co M; Li J; Ramakrishnan V; Dunne K; Opat SS; Gregory GP
    Blood Adv; 2023 Jul; 7(14):3531-3539. PubMed ID: 36947202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic leukemia at Children's Hospitals in the United States.
    Gupta A; Damania RC; Talati R; O'Riordan MA; Matloub YH; Ahuja SP
    J Adolesc Young Adult Oncol; 2021 Dec; 10(6):645-653. PubMed ID: 33512257
    [No Abstract]    [Full Text] [Related]  

  • 5. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
    Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
    Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mutational spectrum of adult T-ALL.
    Neumann M; Vosberg S; Schlee C; Heesch S; Schwartz S; Gökbuget N; Hoelzer D; Graf A; Krebs S; Bartram I; Blum H; Brüggemann M; Hecht J; Bohlander SK; Greif PA; Baldus CD
    Oncotarget; 2015 Feb; 6(5):2754-66. PubMed ID: 25595890
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.